Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danhson is a Bulgaria-based pharmaceutical holding and operating company founded in 2015 that develops, manufactures, markets, and sells prescription medicines, over-the-counter products, food supplements, and cosmetics. The company presents itself as an international group with operations across Bulgaria, the Balkans, CIS countries, and parts of Asia. Its business appears centered on commercialized finished-dose products rather than a disclosed innovative clinical pipeline. Danhson also highlights in-house R&D laboratory capabilities and pharmaceutical production operations, alongside trading and distribution activities. Overall, it is best characterized as a regional commercial pharmaceutical manufacturer and marketer rather than a venture-stage biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danhson.